Loading organizations...
§ Private Profile · Madison, WI, USA
iPSC-derived human cell manufacturer providing cell products for drug discovery, research, and regenerative medicine.
Cellular Dynamics International is a Madison, Wisconsin-based biotechnology company that manufactures human cells derived from induced pluripotent stem cells for research, drug discovery, and regenerative medicine. The organization produces standardized iCell and custom MyCell products, supplying materials to researchers and major pharmaceutical companies for safety testing and therapeutic development. Prior to its acquisition, the enterprise generated $16.7 million in annual revenue, maintained 155 employees, and secured a portfolio of over 900 patents. In March 2015, the business was acquired by Fujifilm Holdings for $307 million, subsequently operating as a wholly owned subsidiary within the broader corporate structure. Following the transaction, the entity divided its operations into dedicated life science and therapeutics units while opening a $21 million manufacturing facility. Cellular Dynamics International was founded in 2004 by James Thomson, Craig January, and Timothy Kamp.
Cellular Dynamics International has raised $70.6M across 2 funding rounds.
Cellular Dynamics International has raised $70.6M in total across 2 funding rounds.
Cellular Dynamics International has raised $70.6M in total across 2 funding rounds.
Cellular Dynamics International's investors include Tactics II Stem Cell Ventures, Sam Zell, G-force, Sixth Floor Investors, Leonard Loventhal.
Cellular Dynamics International has raised $70.6M across 2 funding rounds. Most recently, it raised $30.0M Series B in April 2011.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 7, 2011 | $30M Series B | Tactics II Stem Cell Ventures | SAM Zell, G Force, Sixth Floor Investors | Announced |
| Apr 27, 2010 | $40.6M Series B | Tactics II Stem Cell Ventures | SAM Zell, Leonard Loventhal | Announced |